e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Myriad Genetics Inc
(NQ:
MYGN
)
25.21
USD
-0.40 (-1.56%)
Streaming Delayed Price
/ Updated:
12:40 PM EST, Dec 9, 2019
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
175,547
Open
25.67
Bid (Size)
25.20 (1)
Ask (Size)
25.22 (1)
Prev. Close
25.61
Today's Range
25.12 - 25.97
52wk Range
20.10 - 48.40
Shares Outstanding
69,906,818
Dividend Yield
N/A
Performance
YTD
-13.07%
-13.07%
1 Month
+6.64%
+6.64%
3 Month
+3.15%
+3.15%
6 Month
+4.43%
+4.43%
1 Year
-19.20%
-19.20%
Top News
More News
Myriad’s Prequel™ Prenatal Screen has Superior Sensitivity in Women with High BMI Undergoing Non-Invasive Prenatal Screening
December 04, 2019
from
GlobeNewswire News Releases
Myriad Genetics to Present Multiple Studies on Breast Cancer at the 2019 San Antonio Breast Cancer Symposium
December 03, 2019
from
GlobeNewswire News Releases
More News
Read More
CLASS ACTION UPDATE for OSTK, MYGN and GRUB: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
November 26, 2019
from
ACCESSWIRE
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SEE, MYGN, ZEN and YJ
November 26, 2019
from
GlobeNewswire News Releases
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of MYGN, CC and ET
November 25, 2019
from
ACCESSWIRE
SHAREHOLDER ALERT: MYGN TEUM ACB: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
November 25, 2019
from
ACCESSWIRE
Myriad Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Myriad Genetics, Inc. To Contact The Firm
November 25, 2019
from
NewMediaWire
MYGN FINAL DEADLINE: ROSEN LAW FIRM Reminds Myriad Genetics, Inc. Investors of Tuesday Deadline in Securities Class Action – MYGN
November 25, 2019
from
GlobeNewswire News Releases
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MYGN, DOMO and PLT
November 24, 2019
from
ACCESSWIRE
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Myriad Genetics, Inc. and Encourages Investors to Contact the Firm
November 23, 2019
from
PR Newswire
4-DAY DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Myriad Genetics (MYGN) Investors Who Suffered Significant Losses to Contact Its Attorneys, Application Deadline is Approaching
November 22, 2019
from
GlobeNewswire News Releases
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.